(Press-News.org) Amsterdam, September 9, 2015 - A new Ebola test that uses magnetic nanoparticles could help curb the spread of the disease in western Africa. Research published in Biosensors and Bioelectronics shows that the new test is 100 times more sensitive than the current test, and easier to use. Because of this, the new test makes it easier and cheaper to diagnose cases, enabling healthcare workers to isolate patients and prevent the spread of Ebola.
The authors of the study, from the Chinese Academy of Sciences, say their new technology could be applied to the detection of any biological molecules, making it useful to diagnose other infectious diseases, like flu, and potentially detect tumors and even contamination in wastewater.
The Ebola virus causes an acute illness that is deadly in half of all cases, on average. The current outbreak of Ebola, which started in March 2014, affects countries in west Africa. In the most severely affected countries, like Guinea, Liberia and Sierra Leone, resources are limited, making control of the outbreak challenging. There is no vaccine for Ebola, so detecting the virus is key to controlling the outbreak: with an accurate diagnosis, patients can be isolated and treated properly, reducing the risk of spread.
"In west Africa, resources are under pressure, so complicated, expensive tests are not very helpful," said Professor Xiyun Yan, one of the authors of the study from the Chinese Academy of Sciences. "Our new strip test is a simple, one-step test that is cheap and easy to use, and provides a visible signal, which means people don't need training to use it. We think it will be especially helpful in rural areas, where technical equipment and skills are not available."
Currently there are two ways to test for the Ebola virus: using a method called polymerase chain reaction (PCR), which makes copies of the molecules for detection, and with antibody-capture enzyme-linked immunosorbent assay (ELISA), which gives a visual indication when a given molecule is in a sample. PCR is very sensitive, but is expensive and complicated, requiring special skills and technical equipment. The ELISA - or gold strip test - is cheaper but sensitivity is very low, which means it often gives the wrong results.
The new test, called the nanozyme test, uses magnetic nanoparticles, which work like enzymes to make the signal stronger, giving a clearer result you can see with the naked eye. The test can detect much smaller amounts of the virus, and is 100 times more sensitive than the gold strip test.
"People have loved the strip test for many years, but it has a major weakness: it's not sensitive enough. We're very excited about our new nanozyme test, as it is much more sensitive and you don't need any specialist equipment to get a quick, accurate result," said Dr. Yan.
Strip tests work by attaching molecules called antibodies to gold particles to look for a particular molecule in a sample. When they attach to the molecule you're looking for, in this case a virus, they produce a signal, such as a color change. In order to find the virus, the particles need to be labelled with enzymes, which speed up detection and signalling.
With the new nanozyme test, the researchers applied magnetic nanoparticles as a nanozyme probe in place of gold nanoparticles. After labeling with an antibody that attaches to the Ebola virus, this novel probe is able to recognize and separate the virus in a sample. The nanoparticles are magnetic, so to concentrate the virus particles in a sample, all you need to do is hold the sample against a magnet; no expensive equipment is needed.
The nanozyme test is 100 times more sensitive than the gold strip test, detecting molecules called glycoproteins on the surface of the Ebola virus at concentrations as low as 1 nanogram per milliliter.
The researchers have applied for a patent for the new test, which is currently being taken to west Africa by the CDC to use in the field. The researchers are also collaborating with clinical teams to apply the technology to other diseases, and with a company that treats wastewater to see if it can help remove environmental contamination.
INFORMATION:
Article details
"Nanozyme-strip for rapid local diagnosis of Ebola" by Demin Duan, Kelong Fan, Dexi Zhang, Shuguang Tan, Mifang Liang, Yang Liu, Jianlin Zhang, Panhe Zhang, Wei Liu, Xiangguo Qiu, Gary P. Kobinger, George Fu Gao, Xiyun Yan (doi: 10.1016/j.bios.2015.05.025). The article appears in Biosensors and Bioelectronics, published by Elsevier.
A copy of the paper is available to credentialed journalists upon request, contact Elsevier's Newsroom at newsroom@elsevier.com or +31 20 4853564.
About Biosensors and Bioelectronics
Biosensors & Bioelectronics is the principal international journal devoted to research, design, development and application of biosensors and bioelectronics. It is an interdisciplinary journal serving professionals with an interest in the exploitation of biological materials and designs in novel diagnostic and electronic devices including sensors, DNA chips, electronic noses, lab-on-a-chip and μ-TAS. http://www.journals.elsevier.com/biosensors-and-bioelectronics
About Elsevier
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions -- among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey -- and publishes over 2,500 journals, including The Lancet and Cell, and more than 33,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group plc, a world-leading provider of information solutions for professional customers across industries.
http://www.elsevier.com
Media contact
Darren Sugrue
Elsevier
+31 20 485 3506
d.sugrue@elsevier.com
WASHINGTON, DC (September 9, 2015) -- Women are not only at greater risk of developing Alzheimer's disease (AD) when compared to men; per capita, they also bear six times the cost of AD care that men do, reports a study published today in the journal Women's Health Issues. Authors Zhou Yang of Emory University's Rollins School of Public Health and Allan Levey of the Emory University School of Medicine used a lifetime perspective to calculate AD costs to women and men based on three factors: the probability of developing AD, the disease's duration, and the required formal ...
Within the past few years, a new technology has made altering genes in plants and animals much easier than before. The tool, called CRISPR/Cas9 or just CRISPR, has spurred a flurry of research that could one day lead to hardier crops and livestock, as well as innovative biomedicines. But along with potential benefits, it raises red flags, according to an article in Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society.
Ann M. Thayer, a senior correspondent at C&EN, notes that scientists have long had the ability to remove, repair ...
In today's smart home, technologies can track how much energy a particular appliance like a refrigerator or television or hair dryer is gobbling up. What they don't typically show is which person in the house actually flicked the switch.
A new wearable technology developed at the University of Washington called MagnifiSense can sense what devices and vehicles the user interacts with throughout the day, which can help track that individual's carbon footprint, enable smart home applications or even assist with elder care.
In a study to be presented this week at the ...
Irvine, Calif., Sept. 7, 2015 - Astronomers from the University of California, Irvine and Baltimore's Space Telescope Science Institute have generated the most accurate statistical description yet of faint, early galaxies as they existed in the universe 500 million years after the Big Bang.
In a research paper published today in Nature Communications, the team describes its use of a new statistical method to analyze Hubble Space Telescope data captured during lengthy sky surveys. The method enabled the scientists to parse out signals from the noise in Hubble's deep-sky ...
Privately insured pregnant women are less likely to have C-sections when their regular care includes midwives and 24-hour obstetrician coverage, according to a study by researchers at UC San Francisco and Marin General Hospital.
The study published online in Obstetrics & Gynecology, on Sept. 8, compared the number of C-sections among women with private insurance, before and after an overhaul of staff practices at Marin General Hospital.
Prior to April 2011, private patients at this community hospital in Northern California were managed under a conventional model, in ...
BEER-SHEVA, Israel...September 9, 2015 -- Ben-Gurion University of the Negev (BGU) research demonstrates how Jewish mothers' emphasis on the many aspects of well being, fitness and a sense of self-fulfillment helps to counteract the innumerable "ideal" body images seen and heard by their daughters in the mass media.
The new study published in Feminism and Psychology focuses on how Jewish mothers instilled resilience in their daughters to combat body dissatisfaction, which can lead to eating disorders. It included 20 pairs of mothers and adult-age daughters and eight other ...
With an ever increasing number of everyday objects from our homes, workplaces and even from our wardrobes, getting connected to the Internet, known as the 'Internet of Things (IoT), researchers from the University of Southampton have identified easy-to-use techniques to configure IoT objects, to make them more secure and hence help protect them from online attacks.
This increased connectivity brings additional risk. Setting personalised and strong passwords when connecting new devices to the Internet, for example through our home Wi-Fi networks, can mitigate such risks. ...
Liverpool, 9 September 2015 - A new systematic review of animal studies testing a vaccine for tuberculosis raises questions about whether the studies provided sufficient evidence to move into trials of children.
The new vaccine was a virus-expressing antigen 85A (MVA85A) designed to boost the immunity offered by the existing Bacillus Calmette-Guérin (BCG) vaccine which has little protective effect in practice. The review, published today in the International Journal Epidemiology, evaluates the animal evidence that contributed to the decision to conduct human studies. ...
A new regulation adopted by the European Parliament and the Council will allow customs to access information to track the origins and routes of cargo containers arriving in the EU. This new capability will support the fight against customs fraud both at EU and national level. The JRC has been instrumental in the conception and adoption of this legislation by providing the scientific evidence on the importance of analysing electronic records on cargo container traffic.
The EU customs authorities have been long aware that information on the logistics and actual routes of ...
Most people are familiar with the double-helix shape that allows genetic information to be packed into a molecule of human DNA. Less well-known is how all this information - which, if laid end-to-end, would stretch some three meters - is packed into the cellular nucleus. The secret of how this crush of genetic code avoids chaos - remaining untangled, correctly compartmentalized, and available for accurate DNA replication - has recently been revealed.
By tracking and analyzing the movement of fluorescently-tagged genomic regions within the nuclei of live cells, an international ...
